Raymond Ruff

Science TLDR

Ten-minute paper summaries for scientists and experts. Two episodes a week: Mondays feature the top-scoring paper from a curated weekly digest of T cell engager, bispecific antibody, and protein engineering literature. Fridays cover the top trending paper on PubMed — any field, whatever's catching the research community's attention that week. Hosted by Raymond Ruff, a protein scientist working in translational immunotherapeutics. Audio is generated with NotebookLM; the host prompt aims for measured scientific skepticism rather than hype. Feedback and paper suggestions: sciencetldrpod@gmail.com

Vizitează neapărat site-ul podcastului și susține-i creatorul: raymondruff.github.io

Autor

Raymond Ruff

Categorie

Science

Site-ul podcastului

raymondruff.github.io

Cel mai nou episod

20 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

Episode 102: Trending — Recombinant Canine Coronaviruses in Dogs, Europe 20.11.2026

Top Trending Friday — our weekly pick of the most-discussed paper on PubMed this week. Recombinant Canine Coronaviruses in Dogs, Europe Emerging Infectious Diseases, 2010 DOI: 10.3201/eid1601.090726 Question: How common in European dogs are canine coronavirus (CCoV) type II strains whose spike 5' end is recombinant with porcine TGEV? Answer: In 1,172 faecal samples from dogs with enteritis in 14 c...

Episode 101: Seasonal variations of functional connectivity of human brains 18.11.2026

Seasonal variations of functional connectivity of human brains Scientific Reports, 2023 DOI: 10.1038/s41598-023-43152-4 Question: Does resting-state fMRI activity and connectivity differ with the season in which a person is scanned? Answer: In 410 Human Connectome Project adults, each measured at one time of year, low-frequency signal power (fALFF) and some connectivity measures peaked in autumn....

Episode 100: T cell–mediated antibody-dependent cellular cytotoxicity provides a therapeutic approach for solid cancers 16.11.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. T cell–mediated antibody-dependent cellular cytotoxicity provides a therapeutic approach for solid cancers JCI Insight, 2026 DOI: 10.1172/jci.insight.205984 Question: Can the native FcγRI signalling module's antigen-density threshold make redirected T cell killing tumour-selective? Answer: AG2G T cells signalled only ab...

Episode 99: Reddit Trending — Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation 13.11.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation PLOS Medicine, 2026 DOI: 10.1371/journal.pmed.1004772 Question: Did the $79.4 billion spent developing and delivering COVID-19 vaccines in 2020–21 pay off globally in the first year...

Episode 98: Biomolecular design through latent reasoning with RFD4-Proteina 11.11.2026

Biomolecular design through latent reasoning with RFD4-Proteina White paper — UW Institute for Protein Design & NVIDIA, 2026 Source: https://rfd4-proteina.org/assets/paper/RFD4-Proteina.pdf Question: Can one generative model span proteins, sugars, DNA and RNA in a shared latent space, and does inference-time compute improve real design success? Answer: On the authors' own AF3-judged benchmarks...

Episode 97: Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments. 10.11.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments Molecular Cancer Therapeutics, 2026 DOI: 10.1158/1535-7163.MCT-25-1542 Question: Does HERV-K (HML-2) envelope mark clinically relevant DLBCL states, and is it a usable surface target? Answer: HERV expression mirrors the ABC...

Episode 96: Reddit Trending — The dietary fibre content of fruit and vegetable kitchen preparation waste and UK consumers’ dietary fibre-related attitudes regarding its consumption 07.11.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. The dietary fibre content of fruit and vegetable kitchen preparation waste and UK consumers' dietary fibre-related attitudes regarding its consumption International Journal of Food Sciences and Nutrition, 2026 DOI: 10.1080/09637486.2026.2734852 Question: Do discarded peels, stalks, cores and seeds of 12 fruits...

Episode 95: Shared α-helix chimeraffibodies enable linker-free bispecific protein design 04.11.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Shared α-helix chimeraffibodies enable linker-free bispecific protein design Cell Chemical Biology, 2026 DOI: 10.1016/j.chembiol.2026.09.022 Question: Can two α-helical binding domains be fused by sharing a single helix instead of a flexible linker, without destroying either paratope? Answer: Yes for one lineage: the le...

Episode 94: Reddit Trending — The Effect of Deactivating Facebook and Instagram on Users’ Emotional State 01.11.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. The Effect of Deactivating Facebook and Instagram on Users’ Emotional State American Economic Journal: Economic Policy, 2024 DOI: 10.1257/pol.20240806 Question: Does deactivating Facebook or Instagram for six weeks improve users' self-reported happiness, depression and anxiety? Answer: Facebook deactivation imp...

Episode 93: Reddit Trending — Associations of food processing and dietary risk factors with colorectal cancer incidence in the NIH-AARP Diet and Health Study: A cohort study 23.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Associations of food processing and dietary risk factors with colorectal cancer incidence in the NIH-AARP Diet and Health Study: A cohort study PLOS Medicine, 2026 DOI: 10.1371/journal.pmed.1005251 Question: Is total ultra-processed food (UPF) intake associated with colorectal cancer, and which nutrients inside...

Episode 92: Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism 19.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism Nature, 2026 DOI: 10.1038/s41586-026-11176-1 Question: Can IL-10 receptor agonism be made to suppress myeloid cells without also activating T cells, which drives IL-10's clinical toxicity? Answer: A tetravalent nanobody agonist (lead E07/A05) su...

Episode 91: Reddit Trending — “It’s Like You’re Trying to Defuse a Bomb”: <i>Fear, Responsibility, and Shame in Young Men’s Sexual Lives</i> 18.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. "It's Like You're Trying to Defuse a Bomb": Fear, Responsibility, and Shame in Young Men's Sexual Lives Journal of Sex &amp; Marital Therapy, 2026 DOI: 10.1080/0092623X.2026.2740624 Question: How do young heterosexual men, raised amid consent-focused sex education, emotionally experience sex? Answer: In 31 inte...

Episode 90: Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to Binders competition 13.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to Binders competition Molecular Systems Biology, 2026 DOI: 10.1038/s44320-026-00246-1 Question: Do AI-designed minibinders function as CAR-T antigen-recognition domains, not just as high-affinity binders in isolation? Answer: Across 12,000 designs fr...

Episode 89: Reddit Trending — Not with a Bang but a Whimper: Congressional Silence Amid an Historic Assault on the Power of the Purse 09.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Not with a Bang but a Whimper: Congressional Silence Amid an Historic Assault on the Power of the Purse PS: Political Science &amp; Politics, 2025 DOI: 10.1017/S1049096525101704 Question: Why has Congress barely resisted President Trump's unilateral impoundments and tariffs, actions that assault its constitutio...

Episode 88: GPCR antagonism via rewiring of receptor trafficking and degradation 07.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. GPCR antagonism via rewiring of receptor trafficking and degradation Nature, 2026 DOI: 10.1038/s41586-026-11088-0 Question: Can bispecific antibodies that hijack transferrin receptor 1 trafficking degrade GPCRs that are hard to block with conventional antagonists? Answer: Yes in overexpression systems and one short-term...

Episode 87: Reddit Trending — Did Donald Trump Receive a Mandate for Sweeping Change in 2024? 06.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Did Donald Trump Receive a Mandate for Sweeping Change in 2024? PS: Political Science &amp; Politics, 2025 DOI: 10.1017/S1049096525101868 Question: Did Trump's 2024 victory and subsequent polling give him a genuine public mandate for the sweeping changes he and his team claimed? Answer: No, by the author's crit...

Episode 86: Specific targeting of MR1-antigen complexes using nanobodies 05.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Specific targeting of MR1-antigen complexes using nanobodies Science Immunology, 2025 DOI: 10.1126/sciimmunol.aeb8726 Question: Can nanobodies be raised to selectively recognize MR1 only when it presents a spec

Episode 85: Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits 04.10.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits Cell, 2026 DOI: 10.1016/j.cell.2026.08.002 Question: Can genome-scale CRISPRi perturb-seq in primary human CD4+ T cells, at rest and after stimulation, map which genes regulate T cell states...

Episode 84: Reddit Trending — Predictors and prevalence of support for white nationalism in the United States 03.10.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Predictors and prevalence of support for white nationalism in the United States Nature, 2026 DOI: 10.1038/s41586-026-11018-0 Question: How common is explicit, informed support for white nationalism among white US adults, and what predicts it? Answer: In a probability sample, 4.9% (CI 3.6–6.2) of non-Hispanic wh...

Episode 83: Discovery and engineering of bispecific TCR-mimic antibodies targeting peptide–HLA complex 26.09.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Discovery and engineering of bispecific TCR-mimic antibodies targeting peptide–HLA complex mAbs, 2026 DOI: 10.1080/19420862.2026.2731282 Question: Can building proteome-wide off-target counter-screening into TCR-mimic antibody discovery yield more specific WT1-targeting bispecifics than published comparators? Answer: Th...

Episode 82: Trending — Substantial under-detection of human rabies cases in the United States 25.09.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Substantial under-detection of human rabies cases in the United States Communications Health, 2026 DOI: 10.1038/s44528-026-00031-4 Question: Using rare transplant-transmitted rabies events as a proxy sample of undiagnosed deaths, how many US rabies deaths does official surveillance actually miss? Answer: Scalin...

Episode 81: A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability 25.08.2026

Monday Immune Engager — our weekly pick from the latest immune-engager digest. Paper: A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability Authors: M. Frank Erasmus, Daniel Bedinger, Elizabeth Hopkins, Ginger Ferguson, et al. Journal: Nature Biotechnology, 2026 Why it matters: This CASP-style blinded benchmark—testing 511 AI-designed...

Episode 80: Trending — Educational expansion and the hidden reversal of the Flynn effect—Differential trends across socioeconomic strata 22.07.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Paper: Educational expansion and the hidden reversal of the Flynn effect—Differential trends across socioeconomic strata Authors: Bernt Bratsberg, Anders M. Fjell, Ole J. Rogeberg, Kristine B. Walhovd Journal: Proceedings of the National Academy of Sciences, 2025 Why it matters: The apparent plateau and reversa...

Episode 79: Trending — Probability of a timely vocal response in mother-infant interaction and later psychiatric diagnosis: A case-control study 16.07.2026

Top Trending Friday — our weekly pick of the top-trending paper on r/science this week. Paper: Probability of a timely vocal response in mother-infant interaction and later psychiatric diagnosis: A case-control study Authors: Bethany Stanley, Clare S. Allely, Jenna Charlton, Christopher Gillberg, et al. Journal: PLOS One, 2024 Why it matters: A single timing metric — whether a mother vocalizes bac...

Episode 78: Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation 06.07.2026

**Monday Immune Engager** — our weekly pick from the latest immune-engager digest. **Paper:** [Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation](https://doi.org/10.1002/anie.5894316) **Authors:** Fengzhen Zhang, Yuhan Dong, Kailu Liu, Hui Hu, et al. **Journal:** Angewandte Chemie International Edition, 2025 **Why it matter...

Ascultă podcastul Science TLDR în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice